Since my last Novo Nordisk ( NVO ) analysis , the stock has lost 10.5% in price. We are in official deep value territory here, and I am considering buying, as I firmly believe the bottom is in.Analyst’s Disclosure:I/we have a beneficial long position in the shares of NVO, LLY either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with ...